Positron molecular imaging, an in vivo glimpse of the genome

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 1, 2007, Pages 11-14

  Beanlands, Rob ^a,c   Roberts, Robert ^b,c  

^a National Cardiac PET Centre   (Canada)

^b Ruddy Canadian Cardiovascular Genetics Centre   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC IMAGING; EDITORIAL; GENE ACTIVATION; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME; HUMANS; POSITRON-EMISSION TOMOGRAPHY;

EID: 34250331592     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.05.001     Document Type: Editorial

References (41)

1. Roberts R., and Gollob M. Molecular cardiology and genetics in the 21st century-a primer. Curr. Probl. Cardiol. 31 (2006) 637-701
2. Roberts R. Genomics and cardiac arrhythmias. J. Am. Coll. Cardiol. 47 (2006) 9-21
3. Chan L. Gene-environment interactions and gene therapy in atherosclerosis. Cardiol. Rev. 2 (1994) 130-137
4. American Heart Association: Heart and Stroke Statistical Update. 2000.
5. World Health Organization. The atlas of heart disease and stroke 2004. 2004:www.who.int.
6. Levin C.S. Primer on molecular imaging technology. Eur. J. Nucl. Med. Mol. Imaging 32 Suppl. 2 (2005) S325-S345
7. Chatziioannou AF. Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT, Proc. Am. Thorac. Soc., 2005;2:533-6, 510-11.
8. Tai Y.C., Ruangma A., Rowland D., Siegel S., Newport D.F., Chow P.L., and Laforest R. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J. Nucl. Med. 46 (2005) 455-463
9. Chatziioannou A.F. Molecular imaging of small animals with dedicated PET tomographs. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 98-114
10. Yoshinaga K., Chow B.J., deKemp R.A., Thorn S., Ruddy T.D., Davies R.A., DaSilva J.N., and Beanlands R. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr. Pharm. Des. 11 (2005) 903-932
11. Pomper M.G., and Hammoud D.A. Positron emission tomography in molecular imaging. Could the promise of personalized patient care be reaching fruition?. IEEE Eng. Med. Biol. Mag. 23 (2004) 28-37
12. Wu J.C., and Yla-Herttuala S. Human gene therapy and imaging: cardiology. Eur. J. Nucl. Med. Mol. Imaging 32 Suppl. 2 (2005) S346-S357
13. Meoli D.F., Sadeghi M.M., Krassilnikova S., Bourke B.N., Giordano F.J., Dione D.P., Su H., Edwards D.S., Liu S., Harris T.D., Madri J.A., Zaret B.L., and Sinusas A.J. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J. Clin. Invest. 113 (2004) 1684-1691
14. Chen X., Tohme M., Park R., Hou Y., Bading J.R., and Conti P.S. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol. Imaging 3 (2004) 96-104
15. Beer A.J., Haubner R., Wolf I., Goebel M., Luderschmidt S., Niemeyer M., Grosu A.L., Martinez M.J., Wester H.J., Weber W.A., and Schwaiger M. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. J. Nucl. Med. 47 (2006) 763-769
16. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., and Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
17. Kang W.J., Kang H.J., Kim H.S., Chung J.K., Lee M.C., and Lee D.S. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J. Nucl. Med. 47 (2006) 1295-1301
18. Bengel F.M., Schachinger V., and Dimmeler S. Cell-based therapies and imaging in cardiology. Eur. J. Nucl. Med. Mol. Imaging 32 Suppl. 2 (2005) S404-S416
19. Bengel F.M., Anton M., Avril N., Brill T., Nguyen N., Haubner R., Gleiter E., Gansbacher B., and Schwaiger M. Uptake of radiolabeled 2′-fluoro-2′-deoxy-5-iodo-1-beta-d-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation 102 (2000) 948-950
20. Wu J.C., Inubushi M., Sundaresan G., Schelbert H.R., and Gambhir S.S. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106 (2002) 180-183
21. Bengel F.M., Anton M., Richter T., Simoes M.V., Haubner R., Henke J., Erhardt W., Reder S., Lehner T., Brandau W., Boekstegers P., Nekolla S.G., Gansbacher B., and Schwaiger M. Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108 (2003) 2127-2133
22. Chang GY, Cao F, Krishnan M, Xie X, Sheikh A, Li Z, Huang M, Robbins R, Hsiai T, Schneider MD, Wu JC. Positron emission tomography imaging of conditional gene activation in the heart. In; (2006).
23. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev., Genet. 2 (2001) 743-755
24. Chien K.R. To Cre or not to Cre: the next generation of mouse models of human cardiac diseases. Circ. Res. 88 (2001) 546-549
25. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 (2000) 898-901
26. Heine H.L., Leong H.S., Rossi F.M., McManus B.M., and Podor T.J. Strategies of conditional gene expression in myocardium: an overview. Methods Mol. Med. 112 (2005) 109-154
27. Wu J.C., Chen I.Y., Wang Y., Tseng J.R., Chhabra A., Salek M., Min J.J., Fishbein M.C., Crystal R., and Gambhir S.S. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 110 (2004) 685-691
28. Yang Y., Li Q., Ertl H.C., and Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69 (1995) 2004-2015
29. Yla-Herttuala S., and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9 (2003) 694-701
30. Sumner-Jones S.G., Davies L.A., Varathalingam A., Gill D.R., and Hyde S.C. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways. Gene Ther. 13 (2006) 1703-1713
31. Ruel M., Beanlands R., Lortie M., deKemp R.A., Chan V., Rubens F., Suuronen E., DaSilva J.N., Sellke F.W., Stewart D.J., and Mesana T.G. Concomitant treatment with oral l-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the endothelial modulation in angiogenic therapy (EMAT) randomized controlled trial. 87th Annual American Association for Thoracic Surgery Meeting. Washington, DC (2007) (Abstract)
32. Kudo T., Fukuchi K., Annala A.J., Chatziioannou A.F., Allada V., Dahlbom M., Tai Y.C., Inubushi M., Huang S.C., Cherry S.R., Phelps M.E., and Schelbert H.R. Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph. Circulation 106 (2002) 118-123
33. Croteau E., Benard F., Cadorette J., Gauthier M.E., Aliaga A., Bentourkia M., and Lecomte R. Quantitative gated PET for the assessment of left ventricular function in small animals. J. Nucl. Med. 44 (2003) 1655-1661
34. Croteau E., Benard F., Bentourkia M., Rousseau J., Paquette M., and Lecomte R. Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. J. Nucl. Med. 45 (2004) 1924-1930
35. Sharpe T.L., Dence C.S., Engelbach J.A., Herrero P., Gropler R.J., and Welch M.J. Techniques necessary for multiple tracer quantitative small-animal imaging studies. Nucl. Med. Biol. 32 (2005) 875-884
36. Stegger L., Hoffmeier A.N., Schafers K.P., Hermann S., Schober O., Schafers M.A., and Theilmeier G. Accurate noninvasive measurement of infarct size in mice with high-resolution PET. J. Nucl. Med. 47 (2006) 1837-1844
37. Iwakura A., Fujita M., Kataoka K., Tambara K., Sakakibara Y., Komeda M., and Tabata Y. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18 (2003) 93-99
38. Inubushi M., Jordan M.C., Roos K.P., Ross R.S., Chatziioannou A.F., Stout D.B., Dahlbom M., and Schelbert H.R. Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion. Eur. J. Nucl. Med. Mol. Imaging 31 (2004) 110-116
39. Sundaresan G., Paulmurugan R., Berger F., Stiles B., Nagayama Y., Wu H., and Gambhir S.S. MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene. Gene Ther. 11 (2004) 609-618
40. Lyons S.K., Meuwissen R., Krimpenfort P., and Berns A. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res. 63 (2003) 7042-7046
41. deKemp RA, Yoshinaga K, Beanlands R, Will 3D PET-CT Enable the Routine Quantification of Myocardial Blood Flow? J Nucl Cardiol. (in press).